Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
:JYNT
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.04Last Year’s EPS
-0.24Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -3.99%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there was notable revenue growth and significant progress in franchise expansion, there were also challenges such as a decline in adjusted EBITDA, decreased sales in mature clinics, increased operational costs, and a decline in franchise license sales.Company Guidance
During The Joint Corp.'s Q1 2025 financial results call, the company provided guidance that emphasized its strategic transition to a pure-play franchisor model, with plans to refranchise 93% of its corporate clinics by the end of 2025. Key financial metrics included a 5% increase in system-wide sales to $132.6 million and a 7% rise in revenue from continuing operations compared to Q1 2024. Adjusted EBITDA from continuing operations, however, decreased to $46,000 from $425,000 in the prior year. The company reported comp sales growth of 3% for clinics open thirteen months, with a slight increase to 4% in March 2025, while mature clinics open forty-eight months experienced a 2% decline. The guidance for 2025 is driven by strategic initiatives like dynamic revenue management, enhanced digital marketing, and strengthening franchise relationships, indicating an expected improvement in profitability in 2026 as they fully transition to a franchise model.Revenue Growth
Revenue from continuing operations increased by 7% in Q1 2025 compared to Q1 2024, reaching $13.1 million due to a greater number of franchise clinics.
System-Wide Sales Increase
System-wide sales were $132.6 million, up 5% compared to Q1 2024, demonstrating resilience in the current economic environment.
Franchise Expansion Progress
93% of corporate clinics are under letters of intent (LOIs) for refranchising, showing significant progress towards becoming a pure-play franchisor.
Cost Management
General and administrative (G&A) expenses were reduced to $6.9 million or 53% of revenue, down from 60% of revenue in the same period last year.
---
JYNT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
JYNT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $10.53 | $9.99 | -5.13% |
Mar 13, 2025 | $10.54 | $11.02 | +4.55% |
Nov 07, 2024 | $11.88 | $11.61 | -2.27% |
Aug 08, 2024 | $12.33 | $11.30 | -8.35% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Joint Corp (JYNT) report earnings?
Joint Corp (JYNT) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is Joint Corp (JYNT) earnings time?
Joint Corp (JYNT) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is JYNT EPS forecast?
JYNT EPS forecast for the fiscal quarter 2025 (Q2) is -0.04.
---